alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1



Certification Required by 18 U.S.C. Sec. 1350

(Section 906 of the Sarbanes-Oxley Act of 2002)



In connection with the filing by ADE Corporation (the Company) of the Quarterly Report on Form 10-Q for the fiscal quarter ended
October 31, 2005 (the Report), the undersigned, as the President and Chief Executive Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that, to my knowledge:



| | 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                        |  |  |  |                                      
|----------------------- |  |  |  | -------------------------------------
|                        |  | 
|Date: December 12, 2005 |  |  |  | /s/ Chris L. Koliopoulos             
|                        |  |  |  | Chris L. Koliopoulos, Ph.D.          
|                        |  |  |  | President and Chief Executive Officer
Exhibit 32.1



Written Statement of the President and Treasurer

Pursuant to 18 U.S.C. Section 1350



In connection with the filing of the Annual Report on Form 10-KSB for the fiscal year ended October 31, 2007 (the Report) by Westergaard.Com, Inc. ("Registrant"), the undersigned hereby certifies that, to the best of his knowledge:



1.

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and



2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.





Date:  February 13, 2008



/s/  Anne Straton

Anne Straton

President & Treasurer





A signed original of this written statement required by 18 U.S.C. Section 1350 has been provided to Westergaard.Com, Inc and will be retained by Westergaard.Com, Inc and furnished to the Securities and Exchange Commission or its staff upon request.
Case 3:10-cr-00285-PGS Document 10 Filed 07/14/10 Page 1 of 5 PageID: 13
Case 3:10-cr-00285-PGS Document 10 Filed 07/14/10 Page 2 of 5 PageID: 14
Case 3:10-cr-00285-PGS Document 10 Filed 07/14/10 Page 3 of 5 PageID: 15
Case 3:10-cr-00285-PGS Document 10 Filed 07/14/10 Page 4 of 5 PageID: 16
Case 3:10-cr-00285-PGS Document 10 Filed 07/14/10 Page 5 of 5 PageID: 17
<Page>
                                                                    EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Click Commerce, Inc. (the "Company") on
Form 10-K for the period ended December 31, 2003, as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Michael W. Nelson,
Chief Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:

     (1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operation of the
Company.

A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to the Company and will be retained
by the Company and furnished to the Securities and Exchange Commission or its
staff upon request.

The foregoing certification is being furnished to the Securities and Exchange
Commission as an exhibit to the Form 10-K and shall not be considered filed as
part of the Form 10-K.



Dated:  March 26, 2004                   /s/  Michael W. Nelson
                                         -----------------------
                                         Chief Financial Officer
```

[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5086 Introduced in House (IH)]

108th CONGRESS
  2d Session
                                H. R. 5086

  To suspend temporarily the duty on 2-[[3,3'-Dichloro-4'-[[1-[[(2,4-
   dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-
                  yl]azo]-3-oxo-N-(o-tolyl)butyramide.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 15, 2004

  Mr. Berry introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
  To suspend temporarily the duty on 2-[[3,3'-Dichloro-4'-[[1-[[(2,4-
   dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-
                  yl]azo]-3-oxo-N-(o-tolyl)butyramide.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SUSPENSION OF DUTY ON 2-[[3,3'-DICHLORO-4'-[[1-[[(2,4-
              DIMETHYLPHENYL)AMINO]CARBONYL]-2-OXOPROPYL]AZO][1,1'-
              BIPHENYL]-4-YL]AZO]-3-OXO-N-(O-TOLYL)BUTYRAMIDE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``      9902.35.14       2-[[3,3-Dichloro-  Free         No change        No change        On or before 12/  ''.
                         4-[[1-[[(2,4-                                                      31/2007
                         dimethylphenyl)am
                         ino]carbonyl]-2-
                         oxopropyl]azo][1,
                         1-biphenyl]-4-
                         yl]azo]-3-oxo-N-
                         (o-
                         tolyl)butyramide
                         (CAS No. 78952-72-
                         4) (provided for
                         in subheading
                         3204.17.60)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to articles entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
EXHIBIT
32.2




CERTIFICATION
PURSUANT TO 18 USC, SECTION 1350,


AS
ADOPTED PURSUANT TO SECTION 906


OF
THE SARBANES-OXLEY ACT OF 2002








In
connection with the Quarterly Report of W2 Energy, Inc. (the “Company”) on Form
10-Q for the quarter ended September 30, 2008, as filed with the Securities and
Exchange Commission on or about the date hereof (the “Report”), I, Michael
McLaren, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002,
that:





(1)           The
Report fully complies with the requirements of Sections 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2)           Information
contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.








Dated:     November
      17, 2008
            /s/ 
      Michael McLarenBy:  Michael
      McLarenIts:  Chief
      Financial Officer








A signed
original of this written statement required by Section 906 has been provided to
W2 Energy, Inc. and will be retained by W2 Energy, Inc. and furnished to the
Securities and Exchange Commission or its staff upon request.
##### 



EXHIBIT 31.2
 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
  1.
    
    I have reviewed this Quarterly Report on Form 10-Q of Sucampo Pharmaceuticals, Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this
report;4.
    
    The registrants other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15(d)-15(e)) for the registrant and have:
 (a)
    
    designed such disclosure controls and procedures or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us
by others within those entities, particularly during the period in which this report is
being prepared;(b)
    
    [paragraph omitted in accordance with SEC Release 34-47986];(c)
    
    evaluated the effectiveness of the registrants disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on such
evaluation; and(d)
    
    disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter (the
registrants fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect the registrants internal control
over financial reporting; and
 5.
    
    The registrants other certifying officer(s) and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of registrants board of directors (or persons performing the equivalent
functions):
 (a)
    
    all significant deficiencies and material weaknesses in the design or operation of
internal controls over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information;
and(b)
    
    any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrants internal control over financial reporting.
 Date: November 14, 2007
    /s/ RONALD W. KAISERRonald W. KaiserChief Financial Officer
(Principal Financial Officer)
J. S14005/16

* Former Justice specially assigned to the Superior Court. NON

- PRECEDENTIAL DECISION

– SEE SUPERIOR COURT I.O.P. 65.37

COMMONWEALTH OF PENNSYLVANIA :

: IN THE SUPERIOR COURT OF

PENNSYLVANIA

v. :

: BRETT MARTIN PETERS, : No. 715 MDA 2015

: Appellant :

Appeal from the Order Entered April 8, 2015, in the Court of Common Pleas of York County

Criminal Division at No. CP

- 67

- CR

- 0003267

- 1996

BEFORE: FORD ELLIOTT, P.J.E., PANELLA, J., AND STEVENS, P.J.E.*

JUDGMENT ORDER BY FORD ELLIOTT, P.J.E.: FILED MARCH 08, 2016

Brett Martin Peters appe als, pro se , from the trial court’s April 8, 2015

order denying his petition for expungement of his conviction of harassment

from April 8, 1997. Appellant filed a notice of appeal with the trial court on

April 21, 2015, and the trial court ordered appella nt to file a concise

statement of matters complained of on appeal pursuant to

Pa.R.A.P. 1925(b). Appellant failed to comply with the trial court’s order,

and as a result, his issue on appeal is waived.

As noted by the trial court, our supreme court has e xplicitly stated that

a failure to produce a Rule 1925 statement will result in an appellant’s issues

being waived on appeal.

Our jurisprudence is clear and well

- settled, and firmly establishes that: Rule 1925(b) sets out a simple bright

- line rule, which obligates an appellantJ. S14005/16

- 2

- to file and serve a Rule 1925(b) statement, when so ordered; any issues not raised in a Rule 1925(b) statement will be deemed waived; the courts lack the authority to countenance deviations from the Rule’s terms; the Rule’s provision s are not subject to
ad hoc exceptions or selective enforcement; appellants and their counsel are responsible for complying with the Rule’s requirements; Rule 1925 violations may be raised by the appellate court

sua sponte , and the Rule applies notwithstan ding an appellee’s request not to enforce it; and, if Rule 1925 is not clear as to what is required of an appellant, on

- the

- record actions taken by the appellant aimed at compliance may satisfy the Rule. We yet again repeat the principle first stated in [ Commonwealth v. Lord , 719 A.2d 306, 309 (Pa. 1998)], that must be applied here: “[I]n order to preserve their claims for appellate review, [a]ppellants must comply whenever the trial court
orders them to file a Statement of Matters Complained of on Appeal pursuant to Pa.R.A.P. 1925. Any issues not raised in a Pa.R.A.P. 1925(b)
statement will be deemed waived.”

Commonwealth v. Hill , 16 A.3d 484, 494 (Pa. 2011).

Moreover, even if appellant had filed a Rule 1925 statement, his brief

failed to include citatio ns to relevant statutes or case law, and, as a result,

his claim would have been deemed waived for the purposes of appeal.

Pa.R.A.P. 2119(b

- c). See also Commonwealth v. Janda , 14 A.3d 147,

164 (Pa.Super. 2011); Commonwealth v. Natividad , 938 A.2d 310, 34 0

(Pa. 2007).

Appeal dismissed.J. S14005/16

- 3

-

Judgment Entered.

Joseph D. Seletyn, Esq. Prothonotary

Date: 3/8/2016
[Federal Register Volume 74, Number 134 (Wednesday, July 15, 2009)]
[Notices]
[Page 34322]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-16725]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 13479-000]


FFP Project 63, LLC; Notice of Preliminary Permit Application 
Accepted for Filing and Soliciting Comments, Motions To Intervene, and 
Competing Applications

July 8, 2009.
    On May 22, 2009, FFP Project 63, LLC filed an application for a 
preliminary permit, pursuant to section 4(f) of the Federal Power Act, 
proposing to study the feasibility of the Fort Adams Hydrokinetic 
Project, to be located on the Mississippi River, in Concordia Parish, 
Louisiana and Wilkinson County, Mississippi.
    The sole purpose of a preliminary permit, if issued, is to grant 
the permit holder priority to file a license application during the 
permit term. A preliminary permit does not authorize the permit holder 
to perform any land disturbing activities or otherwise enter upon lands 
or waters owned by others without the owners' express permission.
    The proposed Fort Adams Hydrokinetic Project consists of: (1) 2,693 
proposed 40 kilowatt Free Flow generating units having a total 
installed capacity of 107.72 megawatts; (2) a 3.3-mile-long, 69 
kilovolt transmission line; and (3) appurtenant facilities. The 
proposed Fort Adams Hydrokinetic Project would have an average annual 
generation of 472 gigawatt-hours.
    Applicant Contact: Ramya Swaminathan, Vice President of 
Development, Free Flow Power Corporation, 33 Commercial Street, 
Gloucester, MA 01930; phone: (978) 226-1531.
    FERC Contact: Kim Carter, 202-502-6486.
    Deadline for filing comments, motions to intervene, competing 
applications (without notices of intent), or notices of intent to file 
competing applications: 60 days from the issuance of this notice. 
Comments, motions to intervene, notices of intent, and competing 
applications may be filed electronically via the Internet. See 18 CFR 
385.2001(a)(1)(iii) and the instructions on the Commission's Web site 
under the ``e-Filing'' link. If unable to be filed electronically, 
documents may be paper-filed. To paper-file, an original and eight 
copies should be mailed to: Kimberly D. Bose, Secretary, Federal Energy 
Regulatory Commission, 888 First Street, NE., Washington, DC 20426. For 
more information on how to submit these types of filings please go to 
the Commission's Web site located at http://www.ferc.gov/filing-comments.asp. More information about this project, including a copy of 
the application, can be viewed or printed on the ``eLibrary'' link of 
Commission's Web site at http://www.ferc.gov/docs-filing/elibrary.asp. 
Enter the docket number (P-13479) in the docket number field to access 
the document. For assistance, call toll-free 1-866-208-3372.

Kimberly D. Bose,
Secretary.
 [FR Doc. E9-16725 Filed 7-14-09; 8:45 am]
BILLING CODE 6717-01-P
```

[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4952 Introduced in House (IH)]

108th CONGRESS
  2d Session
                                H. R. 4952

To suspend temporarily the duty on methacrylamido etheleneurae monomer.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             July 22, 2004

   Mr. Holt introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
To suspend temporarily the duty on methacrylamido etheleneurae monomer.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. METHACRYLAMIDO ETHELENEURAE MONOMER.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``      9902.34.42       Methacrylamido     Free         No change        No change        On or before 12/  ''.
                         etheleneurae                                                       31/2007
                         monomer (CAS No.
                         3089-19-8)
                         (provided for in
                         subheading
                         3824.90.91)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to articles entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
PACTS #: 59889

Name of Sentencing Judicial Officer: THE HONORABLE SUSAN D. WIGENTON

UNITED STATES DISTRICT JUDGE

Date of Original Sentence: 05/10/2012

Original Offense: CONSPIRACY TO DISTRIBUTE OXYCODONE

Original Sentence: 95 months custody, 36 months supervised release, and abide by the following special

conditions: alcohol/drug testing and treatment and mental health treatment

Type of Supervision: Supervised release Date Supervision Commenced: 10/24/2017

NON-COMPLIANCE SUMMARY

The offender has not complied with the following condition(s) of supervision:

Violation Number Nature of Non-Compliance

1 The offender has violated the mandatory supervision condition which states ‘You must refrain

from any unlawful use of a controlled substance. You must submit to one drug test within

15 days of release from imprisonment and at least two periodic drug tests thereafter, as

determined by the Court.’On February 10, 2019, the offender submitted a urine sample which tested positive for cocaineand alcohol use. He denied any new substance use. On February 19, 2019, the National Testing

Laboratory confirmed the urine was positive for benzoylecgonine (a cocaine metabolite).

U.S. Probation Officer Action:

The offender was verbally reprimanded for his recent non-compliance. Our office notified the Court about his substance

use earlier this month. Martinez was recently referred to mental healthlsubstance abuse treatment at Trinitas Hospital.

We will monitor the health of his relationships, two employment positions, substance use, mental health state,

compliance and progress in mental health/substance abuse treatment, as well as his overall activities and associationswithin the community. Our office will notify the Court of any additional instances of non-compliance.

Respectfully submitted,By: Suzanne J. Golda-Martinez

Senior U.S. Probation Officer

Date: 02/22/2019
EX-10.3



 Exhibit 10.3 
 FIRST AMENDMENT 
 TO 

DDR CORP. 

2005 DIRECTORS’ DEFERRED COMPENSATION PLAN 
 (January 1, 2012 Restatement) 
 This First Amendment to DDR Corp. 2005
Directors’ Deferred Compensation Plan (January 1, 2012 Restatement) (the “First Amendment”) is effective as of November 30, 2012 (the “Effective Date”). 

WHEREAS, DDR Corp. (the “Company”) maintains the DDR Corp. 2005 Directors’ Deferred Compensation Plan (the
“Plan”), under an instrument amended and restated effective as of January 1, 2012; and 
 WHEREAS, the
Company desires to amend the Plan. 
 NOW, THEREFORE, pursuant to the power reserved to the Company in paragraph 8 of the
Plan, the Company hereby amends the Plan in the respects hereinafter set forth. 
 1. As of the Effective Date, the first two
sentences of subparagraph 5(a) of the Plan are hereby deleted and replaced with the following: 
 “A Participant shall
elect in writing, at the time such Participant makes each deferral election under subparagraph 4(a), the date on which distribution of the credits to his/her Deferral Account to which the deferral election relates shall commence (the
“Commencement Date”) and the method of distribution, as permitted hereunder. Such election shall specify one of the following Commencement Dates: 
  

	 	(i)	the first day of the seventh month after a Termination of Service; or 

  

	 	(ii)	a specified date that is no later than January 1 following the year in which the Participant attains age 75; or 


 

	 	(iii)	the earlier of the two dates specified in clauses (i) and (ii) above. 

 A “Termination of Service” shall mean a “separation from service” as defined in Treasury Regulation Section 1.409A-1(h).” 

2. As of the Effective Date, the Plan is hereby amended by inserting the following new paragraph 14 immediately after paragraph 13:

 “14. Code Section 409A. Notwithstanding any provision of this Plan to the contrary, if
a Participant is a “specified employee” (within the meaning of Section 409A of the Code and determined pursuant to policies adopted by the Company) on the date of the Participant’s “separation from service” (within the








 
meaning of Treasury Regulation section 1.409A-1(h)) and if any portion of the payments or benefits to be received by the Participant upon his separation from service would constitute a
“deferral of compensation” subject to Section 409A of the Code, then to the extent necessary to comply with Section 409A of the Code, amounts that would otherwise be payable to the Participant pursuant to this Plan during the
six-month period immediately following the Participant’s separation from service will instead be paid or made available on the first day of the seventh month after the date of the Participant’s separation from service.” 

[End of Page] 







 IN WITNESS WHEREOF, the undersigned duly authorized officer of the Company has
executed this instrument effective this 30th day of November, 2012. 
  

			
	DDR CORP.
		
	By:	 	 /s/ Daniel B. Hurwitz



 
			
	Title:	 	C.E.O.